Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Acute Disease 2
- Adolescent 8
- Adult 10
- Advisory Committees 1
- Afghanistan 2
- Aged 3
- Aged, 80 and over 2
- Age Factors 1
- Amino Acid Substitution 2
- Amish 1
- Animals 2
- Antibodies, Neoplasm 1
- Antibodies, Neutralizing 3
- Antibodies, Viral 9
- Antibodies against polioviruses 1
- Antiviral Agents 2
- Article 10
- Articles 1
- Asymptomatic Diseases 1
- Bangladesh 5
- Betacoronavirus 1
- Biological Evolution 1
- Biosurveillance 1
- Birds 1
- Blood Chemical Analysis 1
- Bolivia 1
- Calibration 1
- Capacity Building 1
- Capsid Proteins 1
- Cdc--History 1
- Child 10
- Child, Preschool 11
- China 1
- Cholera 1
- Climate 1
- Clinical Laboratory Techniques 1
- Communicable Disease Control 2
- Coronavirus Infections 4
- CoronaVirus Infections 2
- COVID-19 2
- Disease Eradication 13
- Disease Outbreaks 13
- Enterovirus Infections 2
- Environmental Monitoring 2
- Epidemiological Monitoring 2
- Feces 4
- Female 16
- Full Report 2
- Genome, Viral 3
- Global Health 16
- Guidelines as Topic 2
- Health Personnel 2
- Humans 49
- Immunity, Mucosal 2
- Immunization Programs 3
- Immunization Schedule 6
- Immunologic Deficiency Syndromes 3
- Inactivated polio vaccine 2
- India 2
- Infant 16
- Infant, Newborn 3
- Injections, Intradermal 2
- Intestinal Mucosa 2
- Jordan 2
- Male 16
- Middle Aged 6
- Middle East Respiratory Syndrome CoronaVirus 2
- Middle East Respiratory Syndrome Coronavirus 2
- Models, Theoretical 7
- Myelitis 2
- Pakistan 2
- Polio 2
- Polio immunogenicity 2
- Poliomyelitis 35
- Poliovirus 26
- Poliovirus Vaccine, Inactivated 13
- Poliovirus Vaccine, Oral 24
- Poliovirus Vaccines 2
- Population Surveillance 5
- Practice Guidelines as Topic 3
- Prevalence 3
- Priming 2
- Probability 2
- Prospective Studies 3
- Public Health Administration 2
- Public Health Surveillance 2
- Research Article 2
- Retrospective Studies 2
- Risk 2
- Risk Assessment 5
- Risk Management 10
- Sequence Analysis, DNA 2
- Seroepidemiologic Studies 3
- Serogroup 5
- Severe Acute Respiratory Syndrome 2
- Time Factors 2
- Travel 4
- Vaccination 13
- Virus Shedding 2
- Young Adult 8
Personal Author
Corporate Author
- CDC SARS Coronavirus Sequencing Team 1
- Centers for Disease Control and Prevention (U.S.) 1
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.)Division of Foodborne, Waterborne, and Environmental Diseases. 1
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.)Division of High-Consequence Pathogens and Pathology. 1
- National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. 1
- National Center for Immunization and Respiratory Diseases (U.S.)Division of Viral Diseases. 1
- National Center for Infectious Diseases (U.S.). Division of Viral and Rickettsial Diseases. 1
- National Center for Infectious Diseases (U.S.). Respiratory and Enterovirus Branch 1
Place as Subject
- Africa South of the Sahara 1
- Asia, Southeastern 1
- China 1
- India 2
- Mexico 1
- Nigeria 1
- North America 1
- Pakistan 1
- Saudi Arabia 2
- U.S. 1
- United States 12
Resource Type General
Resource Type Specific
Keywords
- Adolescent 2
- Adult 2
- Age Factors 1
- Bangladesh 2
- Bivalent oral poliovirus vaccine 1
- bOPV 1
- Case-Control Studies 1
- Child 4
- Child, Preschool 3
- Circulating vaccine-derived poliovirus 1
- Disease Eradication 1
- disease outbreak 1
- Disease Outbreaks 2
- disease outbreaks 1
- dynamic modeling 10
- Dynamic modeling 2
- Endemic Diseases 1
- eradication 4
- Eradication 3
- expert judgment 1
- Female 1
- fIPV 1
- Global Health 1
- Health Policy 1
- Humans 7
- Humoral immunity 1
- Immunity, Mucosal 1
- Immunization schedule 1
- Immunogenicity 1
- Inactivated poliovirus vaccine 2
- Incidence 2
- Infant 3
- Infant, Newborn 2
- interdependent risks 1
- Intestinal immunity 1
- IPV 1
- Israel 1
- Japanese encephalitis 1
- Jordan 1
- Laboratory 1
- Legacy 1
- Lithuania 1
- Male 1
- Meningitis 1
- MERS-CoV 1
- Middle Aged 1
- Middle East respiratory syndrome 1
- Models, Biological 1
- mOPV1 1
- Namibia 1
- Networking 1
- novel coronavirus 1
- OPV 2
- Oral polio vaccine 1
- oral poliovirus vaccine 3
- Oral poliovirus vaccine 1
- Outbreak response 1
- outbreak response 1
- outbreak risks 1
- paralysis 1
- polio 5
- Polio 2
- polio-free countries 1
- polio eradication 5
- Polio eradication 2
- Poliomyelitis 8
- poliomyelitis 1
- Polio outbreak response 1
- Poliovirus 6
- poliovirus 1
- poliovirus vaccine 1
- Poliovirus Vaccine, Inactivated 2
- Poliovirus Vaccine, Oral 2
- Poliovirus Vaccines 2
- Population Dynamics 1
- population immunity 1
- risk management 2
- seroepidemiology 1
- Sex Distribution 1
- Surveillance 1
- Topography, Medical 2
- type 1 wild poliovirus 1
- United States 1
- Vaccination 1
- Vaccine preventable diseases 1
- VPD 1
- Young Adult 2
Select all docs (Max 200)
1 -
20 of 61 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Acute Disease (2)
- Adolescent (8)
- Adult (10)
- Advisory Committees (1)
- Afghanistan (2)
- Aged (3)
- Aged, 80 and over (2)
- Age Factors (1)
- Amino Acid Substitution (2)
- Amish (1)
- Animals (2)
- Antibodies, Neoplasm (1)
- Antibodies, Neutralizing (3)
- Antibodies, Viral (9)
- Antibodies against polioviruses (1)
- Antiviral Agents (2)
- Article (10)
- Articles (1)
- Asymptomatic Diseases (1)
- Bangladesh (5)
- Betacoronavirus (1)
- Biological Evolution (1)
- Biosurveillance (1)
- Birds (1)
- Blood Chemical Analysis (1)
- Bolivia (1)
- Calibration (1)
- Capacity Building (1)
- Capsid Proteins (1)
- Cdc--History (1)
- Child (10)
- Child, Preschool (11)
- China (1)
- Cholera (1)
- Climate (1)
- Clinical Laboratory Techniques (1)
- Communicable Disease Control (2)
- Coronavirus Infections (4)
- CoronaVirus Infections (2)
- COVID-19 (2)
- Disease Eradication (13)
- Disease Outbreaks (13)
- Enterovirus Infections (2)
- Environmental Monitoring (2)
- Epidemiological Monitoring (2)
- Feces (4)
- Female (16)
- Full Report (2)
- Genome, Viral (3)
- Global Health (16)
- Guidelines as Topic (2)
- Health Personnel (2)
- Humans (49)
- Immunity, Mucosal (2)
- Immunization Programs (3)
- Immunization Schedule (6)
- Immunologic Deficiency Syndromes (3)
- Inactivated polio vaccine (2)
- India (2)
- Infant (16)
- Infant, Newborn (3)
- Injections, Intradermal (2)
- Intestinal Mucosa (2)
- Jordan (2)
- Male (16)
- Middle Aged (6)
- Middle East Respiratory Syndrome CoronaVirus (2)
- Middle East Respiratory Syndrome Coronavirus (2)
- Models, Theoretical (7)
- Myelitis (2)
- Pakistan (2)
- Polio (2)
- Polio immunogenicity (2)
- Poliomyelitis (35)
- Poliovirus (26)
- Poliovirus Vaccine, Inactivated (13)
- Poliovirus Vaccine, Oral (24)
- Poliovirus Vaccines (2)
- Population Surveillance (5)
- Practice Guidelines as Topic (3)
- Prevalence (3)
- Priming (2)
- Probability (2)
- Prospective Studies (3)
- Public Health Administration (2)
- Public Health Surveillance (2)
- Research Article (2)
- Retrospective Studies (2)
- Risk (2)
- Risk Assessment (5)
- Risk Management (10)
- Sequence Analysis, DNA (2)
- Seroepidemiologic Studies (3)
- Serogroup (5)
- Severe Acute Respiratory Syndrome (2)
- Time Factors (2)
- Travel (4)
- Vaccination (13)
- Virus Shedding (2)
- Young Adult (8)
- CDC SARS Coronavirus Sequencing Team (1)
- Centers for Disease Control and Prevention (U.S.) (1)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.)Division of Foodborne, Waterborne, and Environmental Diseases. (1)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.)Division of High-Consequence Pathogens and Pathology. (1)
- National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (1)
- National Center for Immunization and Respiratory Diseases (U.S.)Division of Viral Diseases. (1)
- National Center for Infectious Diseases (U.S.). Division of Viral and Rickettsial Diseases. (1)
- National Center for Infectious Diseases (U.S.). Respiratory and Enterovirus Branch (1)
- Adolescent (2)
- Adult (2)
- Age Factors (1)
- Bangladesh (2)
- Bivalent oral poliovirus vaccine (1)
- bOPV (1)
- Case-Control Studies (1)
- Child (4)
- Child, Preschool (3)
- Circulating vaccine-derived poliovirus (1)
- Disease Eradication (1)
- disease outbreak (1)
- Disease Outbreaks (2)
- disease outbreaks (1)
- dynamic modeling (10)
- Dynamic modeling (2)
- Endemic Diseases (1)
- eradication (4)
- Eradication (3)
- expert judgment (1)
- Female (1)
- fIPV (1)
- Global Health (1)
- Health Policy (1)
- Humans (7)
- Humoral immunity (1)
- Immunity, Mucosal (1)
- Immunization schedule (1)
- Immunogenicity (1)
- Inactivated poliovirus vaccine (2)
- Incidence (2)
- Infant (3)
- Infant, Newborn (2)
- interdependent risks (1)
- Intestinal immunity (1)
- IPV (1)
- Israel (1)
- Japanese encephalitis (1)
- Jordan (1)
- Laboratory (1)
- Legacy (1)
- Lithuania (1)
- Male (1)
- Meningitis (1)
- MERS-CoV (1)
- Middle Aged (1)
- Middle East respiratory syndrome (1)
- Models, Biological (1)
- mOPV1 (1)
- Namibia (1)
- Networking (1)
- novel coronavirus (1)
- OPV (2)
- Oral polio vaccine (1)
- oral poliovirus vaccine (3)
- Oral poliovirus vaccine (1)
- Outbreak response (1)
- outbreak response (1)
- outbreak risks (1)
- paralysis (1)
- polio (5)
- Polio (2)
- polio-free countries (1)
- polio eradication (5)
- Polio eradication (2)
- Poliomyelitis (8)
- poliomyelitis (1)
- Polio outbreak response (1)
- Poliovirus (6)
- poliovirus (1)
- poliovirus vaccine (1)
- Poliovirus Vaccine, Inactivated (2)
- Poliovirus Vaccine, Oral (2)
- Poliovirus Vaccines (2)
- Population Dynamics (1)
- population immunity (1)
- risk management (2)
- seroepidemiology (1)
- Sex Distribution (1)
- Surveillance (1)
- Topography, Medical (2)
- type 1 wild poliovirus (1)
- United States (1)
- Vaccination (1)
- Vaccine preventable diseases (1)
- VPD (1)
- Young Adult (2)
- :Kisjes, Kasper H. ;Duintjer Tebbens, Radboud J.Nov 01 2014 | J Infect Dis. 210(Suppl 1):S424-S433:Background:Pockets of undervaccinated individuals continue to raise concerns about their potential to sustain epidemic transmission of vaccine prevent...
- :Kalkowska, Dominika A. ;Tebbens, Radboud J. DuintjerOctober 08 2018 | Risk Anal. 39(2):402-413:Since most poliovirus infections occur with no paralytic symptoms, the possibility of silent circulation complicates the confirmation of the end of po...
- :Tong, Suxiang ;Lingappa, Jairam R.August 17 2004 | J Infect Dis. 2004; 190(6):1127-1131:Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) emerged, in November 2002, as a novel agent causing severe respiratory illness. To...
- :Duintjer Tebbens, Radboud J. ;Pallansch, Mark A.Jun 11 2015 | PLoS One. 10(6).:BackgroundFrequent supplemental immunization activities (SIAs) with the oral poliovirus vaccine (OPV) represent the primary strategy to interrupt poli...
- :Bellini, William J. ;Campagnoli, ,R. P.4/23/03:bases 1 to 29727nucleoseq.pdf
- :Walker, Allison Taylor ;Williams, Alford J.Mar 30 2015 | Virology. 482:28-31.:BackgroundThe effect of transport temperature on the viability of poliovirus in stool specimens from paralyzed cases has not been tested. Quality assu...
- :Armstrong, Gregory L. ;Barskey, Albert E.March 2012:The World Health Organization (WHO) Region of the Americas has been a global leader in measles, rubella and congenital rubella syndrome (CRS) eliminat...
- :Pallansch, Mark A.Aug 30 2018 | N Engl J Med. 379(9):801-803
- :Holshue, Michelle L. ;DeBolt, ChasJanuary 31 2020 | N Engl J Med. 2020; 382(10):929-936:An outbreak of novel coronavirus (2019-nCoV) that began in Wuhan, China, has spread rapidly, with cases now confirmed in multiple countries. We report...
- :Kalkowska, Dominika A. ;Franka, RichardApril 29 2020 | Risk Anal. 41(2):289-302:Beginning in 2013, multiple local government areas (LGAs) in Borno and Yobe in northeast Nigeria and other parts of the Lake Chad basin experienced a ...
- :Cowger, Tori L. ;Burns, Cara C.2017 | PLoS One. 12(7):BackgroundMore than 99% of poliovirus infections are non-paralytic and therefore, not detected by acute flaccid paralysis (AFP) surveillance. Environm...
- :Kalkowska, Dominika A. ;Duintjer Tebbens, Radboud J.6 01 2015 | J Infect Dis. 211(11):1800-1812:Background.After 25 years without poliomyelitis cases caused by wild poliovirus (WPV) circulation in Israel, sewage sampling detected WPV type 1 (WPV1...
- :Tebbens, Radboud J. Duintjer ;Pallansch, Mark A.4 2013 | Risk Anal. 33(4):606-646:With the intensifying global efforts to eradicate wild polioviruses, policymakers face complex decisions related to achieving eradication and managing...
- :Yusuf, Nasir ;de Wee, Rosalina11 01 2014 | J Infect Dis. 210(Suppl 1):S353-S360:A paralytic poliomyelitis outbreak occurred in Namibia in 2006, almost exclusively among adults. Nineteen cases were virologically confirmed as due to...
- :Cochi, Stephen L. ;Jafari, Hamid S.11 01 2014 | J Infect Dis. 210(Suppl 1):S1-S4
- :Snider, Cynthia J. ;Zaman, Khalequ9 22 2023 | Vaccine. 41(41):6083-6092:Background:To inform response strategies, we examined type 1 humoral and intestinal immunity induced by 1) one fractional inactivated poliovirus vacci...
- :Duintjer Tebbens, Radboud J. ;Pallansch, Mark A.4 2013 | Risk Anal. 33(4):680-702:The live, attenuated oral poliovirus vaccine (OPV) provides a powerful tool for controlling and stopping the transmission of wild polioviruses (WPVs),...
- :Cochi, Stephen L. ;Pallansch, Mark A.1 04 2021 | J Infect Dis. 223(1):7-9
- :Mach, Ondrej ;Verma, HarishNov 01 2014 | J Infect Dis. 210(0 1):S252-S258.:BackgroundIn 2009, enhanced poliovirus surveillance was established in polio-endemic areas of Uttar Pradesh and Bihar, India, to assess poliovirus inf...
- :Thompson, Kimberly M. ;Pallansch, Mark A.4 2013 | Risk Anal. 33(4):516-543:With the circulation of wild poliovirus (WPV) types 1 and 3 continuing more than a decade after the original goal of eradicating all three types of WP...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.